Related by context. All words. (Click for frequent words.) 76 Neo Kidney Augment 65 MAXY VII 65 Angiocept 65 vosaroxin 65 Azedra ™ 65 Veronate 65 PORxin TM 64 systemic RNAi 64 Trofex 64 TOCOSOL Paclitaxel 64 THR beta agonist 64 Synavive ™ 64 Zemiva TM 64 HCV nucleoside polymerase inhibitors 64 preclinical 64 ONCONASE R 64 novel L DOS# 64 HepeX B 64 Phase 2a clinical trials 63 M Enoxaparin 63 Surfaxin LS 63 reslizumab 63 Charlesson 63 Aganocide 63 VitiGam 63 PDE# inhibitors 63 apricitabine ATC 63 TKM PLK1 63 Chimigen TM 63 GED aPC 63 ApoB SNALP 62 ALN PCS 62 P2V TM 62 HEPLISAV ™ 62 EP #R 62 Anticalin 62 oncolytic virus therapies 62 generation URAT1 inhibitor 62 Solazed TM 62 Kosan dependence 62 selective androgen receptor modulator 62 Aquinox 62 Curaxin CBLC# 62 therapeutic monoclonal antibody 62 novel therapeutic antibodies 62 R#/MEM # 62 PLK1 SNALP 62 HDL Mimetic Peptide 62 tiapamil 62 CEQ# 62 next generation URAT1 62 Stedivaze 62 glucokinase activator 62 candidate TNFerade biologic 62 Protexia ® 61 Shigamabs ® 61 trastuzumab DM1 T DM1 61 TBC# 61 Aganocide ® 61 targeted radiotherapeutic 61 Neo Urinary Conduit 61 candidate CRLX# 61 RIGScan CR 61 PDE4 inhibitor 61 CCX# 61 phase IIa clinical 61 cancer immunotherapies 61 NV1FGF 61 Phase IIb clinical trials 61 Shigamabs R 61 torezolid phosphate 61 potentially treat nephropathic 61 HuMax TAC 61 vaginally administered lidocaine 61 Phase #b/#a clinical 61 Aurexis 61 Fx #A 61 EGS# 61 Cintredekin Besudotox 61 sodium Injection 61 telomerase inhibitor drug 61 PrevOnco ™ 61 Onalta ™ 61 GPR# agonist 61 immunotherapeutic vaccine 61 HuLuc# 61 recombinant biopharmaceutical 61 RGB # 61 Azedra TM 61 PrevOnco 61 phase IIb clinical 61 HepeX B TM 61 MOZOBIL 61 IND submission 61 dextofisopam 61 HuCAL antibodies 61 PANVAC VF 61 DXL# 61 IMA# 61 rxRNA 61 GLP toxicology studies 61 Solazed 61 Aerosurf 61 MAXY G# 61 Azedra 61 oral PTH 61 molecular chaperone regulation 61 Stimuvax R 61 Maxy G# 60 Panzem 60 ALN VSP 60 molecular imaging radiopharmaceutical 60 concerning CombinatoRx 60 humanized monoclonal antibodies 60 preclinical efficacy 60 Tocosol Paclitaxel 60 CMV vaccine 60 Exelixis compounds 60 trodusquemine MSI 60 MAXY alpha 60 including eniluracil ADH 60 lucinactant 60 Exherin TM 60 ICA # 60 Insegia 60 gastro intestinal inflammation 60 DPX Survivac 60 Prednisporin 60 OvaRex R 60 Canvaxin TM 60 drug GAP #B# 60 Nanobody ® 60 Diamyd ® 60 Nanobody R 60 Nanobody 60 TOCOSOL Camptothecin 60 teplizumab 60 TKM ApoB 60 SinuNase ™ 60 Androxal TM 60 Proellex TM 60 Cardio Vascu Grow 60 Adnectin 60 investigational therapies 60 oral prodrug 60 prophylactic vaccine 60 Sulonex 60 aldehyde dehydrogenase ALDH2 deficiency 60 HCD# [002] 60 oral NKTR 60 P#X# antagonist 60 non alcoholic steatohepatitis 60 Memryte 60 JAK inhibitor 60 PREOS R 60 ALN TTR 60 BrachySil TM 59 Trofex TM 59 investigational hepatitis B 59 mertansine 59 SMT C# 59 Prodarsan R 59 BLA filing 59 candidate Puricase 59 StaphVAX R 59 Locteron ® 59 intravenous acetaminophen 59 treat dysmenorrhea 59 otelixizumab 59 OvaRex ® MAb 59 Genasense R oblimersen 59 GLP toxicology 59 ongoing Phase IIIb 59 Prednisporin TM 59 PSN# [002] 59 Iluvien ® 59 iii GTx 59 XOMA 3AB 59 ALTROPANE 59 Nektar proprietary 59 midstage trials 59 IND enabling 59 punctal plug delivery 59 NEUGENE R 59 Mepact 59 Theratope 59 Prodarsan ® 59 predictive toxicology 59 Omigard 59 SPL# Gel vaginal microbicide 59 Tarmogen 59 candidate deforolimus 59 MEK inhibitor RDEA# 59 R#/MEM 59 CB2 selective receptor agonist 59 OncoVEX 59 isoform selective 59 AERx iDMS 59 Civacir 59 ostarine 59 siRNA therapeutics 59 eTag assays 59 Oasmia 59 AzaSite Plus 59 investigational humanized monoclonal antibody 59 CD# CEA 59 XmAb 59 InterfeRx 59 StemEx R 59 PSMA ADC 59 Selective Electrochemical Tumor Ablation 59 RhuDex ® 59 DOS# 59 Nektar PEGylation technology 59 Therapeutic antibodies 59 Specifid 59 Archexin 59 IMC #B 59 Alzhemed TM 59 ALTROPANE R 59 romidepsin novel 59 romazarit 59 alvespimycin 59 PI3K/Akt pathway inhibitor 59 patented Bioral 59 HCV polymerase inhibitor 59 ALN TTR# 59 Lauren Silvernail 59 BACcel 59 Mipomersen 59 Anticalin R 59 bardoxolone 59 Hedgehog agonist 59 OncoVex 58 EndoTAG TM 58 preclinical toxicology 58 PF # [002] 58 Cerashield 58 H#N# VLP vaccine 58 LungExpress Dx TM 58 tafamidis 58 Generx ™ 58 ZaBeCor 58 Guanilib 58 Regado 58 Symadex 58 AclarusDx ™ 58 EVIZON TM squalamine lactate 58 bafetinib 58 Spiegelmer ® 58 LymphoStat B TM 58 acyclovir Lauriad R 58 drug ISA# 58 XL# XL# XL# XL# 58 TLK# 58 novel peptides 58 tramiprosate Alzhemed TM 58 ARIKACE ™ 58 therapeutic peptide 58 ART# 58 GVAX ® 58 Onconase 58 liposomal formulation 58 ALN RSV program 58 maribavir 58 Myocet 58 XmAb ® 58 vaginal lidocaine 58 OMAPRO 58 Acetavance TM intravenous acetaminophen 58 inflammatory autoimmune diseases 58 Allovectin 7 R 58 Anticalin ® 58 Hybridon 58 pharmacological chaperone 58 ZFP Therapeutics 58 Stapled Peptide 58 HCV protease inhibitors 58 Pancreate 58 Allovectin 7 58 KNS # 58 Aurora kinase inhibitors 58 vivo validation 58 Cleviprex TM clevidipine 58 oral taxane 58 candidate ATHX 58 UltiMAb 58 YONDELIS 58 SinuNase TM 58 UVIDEM 58 anticancer compound 58 pradefovir 58 budesonide MMX Phase III 58 StaphVAX 58 SCIB1 58 rALLy trial 58 RNA interference RNAi therapeutics 58 noninvasive prenatal tests 58 omacetaxine mepesuccinate 58 Trofex ™ 58 Evoltra ® 58 candidate REP# 58 NNR Therapeutics 58 CRD5 58 HDL Selective Delipidation 58 URG# 58 forodesine 58 Corlux 58 Ceplene TM 58 Panzem R 58 seliciclib CYC# 58 Alnylam RNAi 58 Bioaccelerate compounds under 58 RNAi therapeutic 58 midstage clinical 58 CORT # 58 UltiMAb ® 58 HCV antiviral 58 Sulonex TM 58 sodium thiosulfate STS 58 sterile lidocaine patch 58 protein kinase inhibitors 58 Alnylam #x# 58 GALNS 58 JAK2 inhibitor 58 intranasal formulation 58 BiTE antibody 58 GeneICE 58 recombinant subunit vaccine 58 Bioral Amphotericin B. 58 skeletal sarcomere activator 58 Intraject 58 nonclinical studies 58 MyVax ® 58 IRX 2 58 Troxatyl 58 XmAb# 58 ularitide 58 immunological diseases 58 TRO# 58 preclinical compounds 58 LentiVector technology 58 Optiquel ™ 58 Chrysalin 58 TOCOSOL 58 adipiplon 58 PHX# 58 epothilone 57 HGS# 57 molecular chaperone amplification 57 tezampanel NGX# 57 cGMP manufacture 57 Ketotransdel 57 ProSavin 57 HQK 57 Hematide ™ peginesatide 57 Junovan TM 57 mSEPT9 biomarker 57 novel RNAi therapeutics 57 OncoVEX GM CSF 57 GRNVAC1 57 TKM Ebola 57 adrenergic regulation 57 molecular imaging radiopharmaceuticals 57 KL4 surfactant 57 ganaxolone 57 Topical Interferon Alpha 2b 57 ATL# [002] 57 preclinical pharmacokinetic 57 maturation inhibition 57 candidate Zenvia 57 IGN# 57 cannabinor 57 Onalta 57 nicotinic alpha 7 57 miRNA therapeutics 57 HCV protease inhibitor 57 deforolimus 57 dirucotide 57 XL# XL# 57 Oral NKTR 57 BLA submission 57 anti CD3 monoclonal 57 personalized cellular immunotherapy 57 proprietary phage display 57 OHR/AVR# 57 intranasal insulin product 57 initiate Phase 1b 57 AVN# [001] 57 Cx# [002] 57 proprietary MSCRAMM protein 57 FOLOTYN ® 57 Factor VIIa 57 denosumab oncology 57 Exelbine 57 non nucleoside HCV 57 Bioral 57 sumatriptan DosePro 57 molecular entities NMEs 57 bioequivalency 57 ENRICH trial 57 RNAi therapeutic targeting 57 Biologic License Application BLA 57 tolevamer 57 Actimmune ® 57 vidofludimus 57 MYDICAR 57 Triolex 57 human IgG1 monoclonal 57 topically applied SEPA 57 Huntexil 57 Panzem R NCD 57 Numoda 57 talactoferrin 57 NADiA 57 Pepducin 57 sodium glucose transporter 57 Zenvia ™ 57 Personalized Immunotherapy 57 anti CD# antibodies 57 developing TB4 57 candidate epratuzumab 57 telomerase therapeutic 57 CRLX# 57 Cytolin R 57 NADiA ProsVue 57 TELINTRA 57 delipidation 57 siRNA therapeutic 57 ATryn ® 57 Xcytrin R 57 NeoLipid drug 57 QTinno TM 57 Hedgehog pathway inhibitor 57 Allovectin 7 r 57 prenatal diagnostics 57 Potelligent Technology 57 ATL# [001] 57 DNA RNA Medicines 57 Phase #b/#a 57 GVAX R 57 outlicensing 57 Pimavanserin 57 initiated Phase 1b 57 entinostat 57 SNS# T 57 NPC 1C 57 Fibrillex TM 57 AE# vaccine 57 MT#/MEDI-# 57 Bicifadine 57 IMPDH inhibitor 57 cyclophilin inhibitors 57 MCSP respectively 57 Nasdaq IDRA today 57 Hedgehog antagonist 57 GVAX cancer 57 TLR8 agonist 57 Biomerk Tumorgraft 57 HIV integrase inhibitors 57 PEG SN# 57 SynCon 57 Spiegelmer 57 Omapro 57 HIV maturation inhibition 57 #D#C# 57 INS# [001] 57 virus HCV protease inhibitor 57 R PEG uricase 57 NurOwn 57 cathepsin K inhibitor 57 inhaled AAT 57 Nanobodies 57 Aplidin 57 Dyax phage display 57 vaccines oncolytic virus 57 NEUGENE 57 liprotamase 57 MassARRAY platform 57 Corus CAD 57 Phase IIa trials 57 Valortim TM 57 Preos 57 synthetic retinoid 57 pralatrexate 57 NP2 Enkephalin 57 BiTE 57 include PLX IBD 57 therapeutic monoclonal antibodies 57 Entereg TM 57 Hemopurifier 57 investigational monoclonal antibody 57 ZFP Therapeutic TM 57 systemic RNAi therapeutic 57 alagebrium 57 midstage studies 57 polysaccharide polymer 57 tezampanel 57 Harbor BioSciences 57 staphylococcal vaccine 57 REMOXY ® 56 punctal plug 56 Cloretazine ® 56 NEUMUNE 56 histamine dihydrochloride 56 AFREZZA ® 56 CCR5 mAb 56 Firazyr ® 56 mitogen activated ERK kinase 56 bicifadine 56 MethyPatch 56 tosedostat 56 multicenter Phase II 56 inhaled liposomal ciprofloxacin 56 candidate XP# 56 Prodarsan 56 Soliris eculizumab 56 ENMD # 56 XP# XP# 56 IV APAP 56 inhibit metastasis 56 Hematide TM 56 FavId 56 file INDs 56 BZL# 56 PRT# 56 Annamycin 56 MEK inhibitor 56 novel histone deacetylase 56 Cutanea 56 Diamyd R 56 SNALP technology 56 unique PER.C6 56 CRMD# 56 Albugon 56 mGluR2 NAM 56 Alequel TM 56 Quinamed 56 MassARRAY ® 56 EGEN 56 Chemokine Therapeutics 56 kidney urologic 56 Dalbavancin 56 volociximab 56 IL# PE 56 Tarvacin TM 56 confirmatory Phase III 56 SNT MC# 56 PEGylated interferon 56 registrational 56 PDX pralatrexate 56 CCR9 antagonist 56 AMPAKINE CX# 56 antisense drug 56 RIGScan 56 Galenea 56 GAP #B# 56 STEDESA 56 ionotropic glutamate receptor antagonists 56 Fentanyl Taifun 56 vilazodone 56 Genasense ® oblimersen 56 oral salmon calcitonin 56 CRACM 56 ELND-#/AZD-# 56 SparVax TM 56 Menerba 56 Phenserine 56 Celator 56 hepatitis B vaccine Heplisav 56 anticoagulant reversing agent 56 Phase 1a clinical 56 Asentar 56 genomic biomarker 56 topical anti infective 56 rheumatoid arthritis thrombocytopenia 56 ZFP Therapeutic 56 refractory gout 56 Posiphen TM 56 Protexia R 56 GSK# [002] 56 Canvaxin 56 CBLC# 56 CCR5 antagonist 56 solanezumab 56 personalized immunotherapy 56 Hemopurifier ® 56 Valortim 56 Voraxaze 56 compound INCB# 56 Zybrestat 56 preclinical studies 56 Phase #/#a trial 56 senicapoc 56 VivaGel TM 56 Bendavia 56 Fodosine 56 immatics 56 indibulin 56 Aurora kinase inhibitor 56 clinical pharmacology studies 56 leading oral taxane 56 tanespimycin 56 CINOD 56 small molecule tyrosine 56 darinaparsin ZIO 56 AQ4N 56 BioVant 56 OMNARIS HFA 56 HepaGam B 56 investigational pan BCR 56 cMET 56 Glybera R 56 ImQuest 56 clinicaltrials 56 postoperative ileus 56 HCV polymerase 56 Bellicum 56 ASONEP 56 HepDirect 56 Micromet BiTE 56 PORxin TM platforms 56 Phase III clinical 56 theranostic 56 PEARL SC 56 Tarvacin Anti Cancer 56 lomitapide 56 Potelligent 56 Zemiva ™ 56 delivers fluocinolone acetonide FA 56 MVA BN R 56 atacicept 56 MGCD# [001] 56 dexanabinol 56 EGRIFTA TM 56 metaglidasen 56 IND Investigational New 56 Vitaxin 56 PDL# 56 platforms GVAX 56 dermatology biopharmaceutical company 56 allosteric modulation 56 Luramist 56 novel oral anticoagulant 56 HGS ETR2 56 omecamtiv mecarbil 56 serine protease inhibitor CU# 56 HuCNS SC ® 56 ongoing Phase 1b 56 MGN# 56 NexACT 56 successfully commercialize Iluvien 56 INCB# [001] 56 ZFNs clinical trials 56 Generx TM 56 candidate Ramoplanin 56 UPLYSO 56 please visit www.advaxis.com 56 HyACT 56 VITAL Trial 56 LEX System 56 SparVax ™ 55 DepoVax ™ 55 rotary VAD 55 DepoVax TM 55 LibiGel ® 55 anti infective treatments 55 avian transgenic 55 ANAVEX #-# [003] 55 BrachySil 55 ALN HTT 55 Phase lll 55 vascular disrupting agents 55 recombinant polyclonal antibody 55 ADME properties 55 Pyridorin 55 commercialize lorcaserin 55 REMOXY R 55 clevudine 55 lintuzumab SGN 55 Squalamine 55 novel anti infective 55 systemic immunosuppressive drugs 55 RenaZorb TM 55 TNFerade TM 55 L BLP# 55 MabThera rituximab 55 proteasome inhibitor 55 CellPort Technologies 55 SEPET TM 55 RhuDex 55 Synavive 55 MOR# 55 MelaFind R 55 Davanat 55 Unit Dose Budesonide 55 Solorel 55 Marqibo TM 55 Duromist ™ 55 Hedgehog inhibitor 55 LEP ETU 55 EndoTAG TM -1 55 pharmacogenetic tests 55 TLR9 agonist 55 biomarker discovery validation 55 radiation sensitizer 55 Aviptadil 55 cystinosis patients 55 R roscovitine 55 postapproval 55 AdhTAP 55 huC# DM4 55 squalamine 55 Inotek Pharmaceuticals Corporation 55 biomarker identification 55 CORLUX 55 LHRH antagonist 55 vaccine GRNVAC1 55 anti botulism antibody 55 Targeted Chemotherapy 55 oral calcitonin 55 GATTEX ® 55 Sym# 55 confirmatory clinical 55 AeroLEF TM 55 Soliris TM eculizumab 55 Lpathomab 55 phase IIa 55 Dacogen injection 55 SARMs 55 Bezielle 55 Vaxfectin 55 Phase Ib study 55 MSCRAMM R 55 ITAX 55 Cloretazine R 55 omecamtiv mecarbil formerly 55 iroxanadine 55 lumiliximab 55 elotuzumab 55 preclinically 55 antisense inhibitors 55 nanopharmaceutical 55 PNP inhibitor 55 vemurafenib 55 incyclinide 55 Vectibix panitumumab 55 Anavex #-# 55 humanized antibodies 55 MorphoSys proprietary 55 oncolytic 55 THALOMID 55 Celladon Corporation 55 TELINTRA R 55 acetonide FA 55 nalbuphine ER 55 PNT# 55 tramiprosate ALZHEMED TM 55 Zemplar Capsules 55 DETERx ™ 55 histone deacetylase HDAC inhibitor 55 Urocidin 55 FM VP4 55 Loramyc TM 55 SPARLON 55 kinase profiling 55 Convivia TM 55 Neuraltus 55 Nuvion 55 HIV protease inhibitor 55 novel VDA molecule 55 AEG# 55 Staccato nicotine technology 55 Nektar pulmonary 55 tubulin inhibitor 55 MAGE A3 ASCI 55 treats acute lymphoblastic 55 Fibrillex 55 Zelrix 55 Homspera TM 55 Vilazodone 55 MSCRAMM 55 alvimopan 55 Aegera 55 NeuVax 55 DCVax R 55 LentiVector 55 DR Cysteamine 55 prostone 55 telaprevir VX 55 candidate AQ4N 55 vivo preclinical 55 immune modulation 55 TÎ ² 4 55 ruxolitinib 55 HCV nucleotide polymerase inhibitor 55 Sopherion 55 neuronal nicotinic receptor NNR 55 CINTREDEKIN BESUDOTOX 55 Phase IIb trials 55 Glassia 55 novel antiviral therapeutics 55 forodesine hydrochloride 55 xMAP technology 55 Neuradiab 55 OXIGON 55 delivery polymer matrix 55 HuMax 55 Collategene 55 Phase IIb III 55 ophthalmology dermatology cardiovascular disease 55 TRIOLEX TM HE# 55 recombinant antibodies 55 cancer indications bafetinib 55 aleglitazar 55 ospemifene 55 MKC# MT 55 CB1 antagonists 55 PEG PAL 55 Phase 2b clinical trials 55 Tolamba 55 OraTest R 55 registrational trials 55 CINQUIL 55 SAR# [002] 55 Adenosine Therapeutics 55 TransMID 55 selective immunoproteasome inhibitor 55 faropenem 55 obatoclax 55 Phase IIa clinical trials 55 GATTEX ™ 55 bevasiranib 55 phase Ib clinical 55 Chimigen 55 #L Ozone Sterilizer 55 schizophrenia CIAS 55 investigational compounds 55 Atiprimod 55 Phase 2a clinical 55 targeting PCSK9 55 Phase IIB 55 Orazol 55 Behcet uveitis 55 pivotal bioequivalence 55 plasmid DNA vaccine 55 BioSante LibiGel Phase III 55 AN# novel 55 Inc. Nasdaq NLTX 55 TLR antagonists 55 AZD# TC 55 Vaccinex 55 RiVax 55 trodusquemine 55 5 HT6 antagonist 55 candidates bavituximab 55 Phase III TRIST 55 Ostabolin C TM 55 Celacade TM 55 EVIZON TM 55 VALOR trial 55 rALLy 55 Lisofylline LSF 55 Lixivaptan 55 BCR ABL inhibitor 55 Rhucin ® recombinant 55 BiTE R 55 phosphatidylserine PS targeting 55 ORADUR ADHD 55 Alexza Staccato 55 PS# [001] 55 targeted antifolate 55 IoGen 55 SERMs 55 QTinno 55 JAK inhibitors 55 VersaFilm 55 REG1 54 EECP ® therapy 54 subsidiaries visit http:/www.apricusbio.com 54 Mycograb 54 LNP formulations 54 monoclonal antibody therapeutics 54 InterfeRx TM 54 SILENOR 54 CobaCyte 54 Lauriad 54 Shigamabs 54 ReN# 54 oral ridaforolimus 54 IL# PE#QQR 54 RNAi therapeutic platform 54 TYZEKA 54 initiated Phase Ib 54 Heplisav 54 Neovasc Reducer 54 BNC# 54 anticancer therapeutics 54 AAG geldanamycin analog 54 Vaxfectin R adjuvant 54 dacetuzumab 54 Vascular Wrap TM 54 NTDDS 54 ADVEXIN clinical 54 davalintide 54 XL# anticancer compounds 54 vitro dissolution 54 Revimmune 54 HuMax CD4 54 RenaZorb 54 motexafin gadolinium Injection 54 biosurgical 54 Zemiva TM Trofex TM 54 Cardioxyl 54 MYDICAR ® 54 SonoLysis 54 Angiolix 54 novel peptide 54 Bioral Amphotericin B 54 biologic therapeutics 54 ZEFTERA TM Zevtera TM 54 Plenaxis TM 54 PREOS 54 vitro ADME 54 ELND# 54 AFFITOME R 54 TELCYTA 54 CR# vcMMAE 54 European Sepsis Trial 54 zileuton CR 54 anidulafungin 54 HepDirect R 54 Alequel ™ 54 Xanafide 54 dimebon latrepirdine 54 ImmunoVEX HSV2 54 Lupuzor 54 Virulizin 54 Tectin TM 54 INTERCEPT red 54 ZEVALIN ® 54 Linjeta TM 54 ViaCyte 54 Neotropix 54 renin inhibitors 54 Aganocide R 54 DAVANAT ® 54 ThermoDox ® clinical 54 POSIDUR TM ELADUR TM 54 Synerx 54 pharmacogenomic translational research 54 BEMA Granisetron 54 HGS ETR1 54 synDNA TM 54 Intravenous CP 54 eniluracil 54 SILENOR TM 54 generation purine nucleoside 54 oral gallium 54 personalized dendritic 54 generation antisense 54 Virulizin R 54 chemical entities NCEs 54 proprietary PEGylation 54 IAP inhibitors 54 enzastaurin 54 NovaBay Aganocide compounds 54 BST CarGel R 54 phase III isavuconazole 54 clinical trials 54 novel anticancer 54 midstage clinical trials 54 Loramyc R 54 proprietary capillary aerosolization 54 blood clot dissolver 54 biomarker validation 54 tramiprosate 54 drug GLPG# 54 rBChE 54 investigational hepatitis C 54 Tumorgraft 54 NicVAX 54 opioid induced bowel dysfunction 54 IMiD 54 ImmunoGen TAP technology 54 cobiprostone 54 #ME# 54 ulimorelin 54 DNA methylation biomarkers 54 VitiGam TM 54 liposomal ciprofloxacin 54 oral talactoferrin 54 Traficet EN 54 EC Cysteamine 54 TRV# [001] 54 Technosphere Insulin 54 Relivar 54 Marqibo 54 please visit http:/www.sunesis.com